Depression News and Research

Latest Depression News and Research

Blue Cross of Massachusetts agrees to reduce dramatic rate increases

In Massachusetts, the state's largest health insurer has agreed to reduce dramatic rate increases for individuals and small businesses.

7 Aug 2010

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Health Affairs: Little Evidence Of Correlation Between Growth In Health Care Spending And Reduced Mortality - This study examines differences in hospital mortality and cost between 2000 and 2004 for patients at 122 U.S. hospitals, with seven common medical diagnoses: acute myocardial infarction, chronic obstructive pulmonary disease, community-acquired pneumonia, congestive heart failure, cerebrovascular accident (also called ischemic stroke), sepsis, or urinary tract infection.

7 Aug 2010

CDS introduces new course on brain injury into its curriculum

The College of Direct Support, an internet-based college for Direct Support Professionals and managed in partnership by Elsevier/MC Strategies and the University of Minnesota's Research and Training Center, has introduced its fourth Disability Intensive Course into the CDS Curriculum - "Brain Injury."

6 Aug 2010

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.

6 Aug 2010

TEMPO study recommends early administration of Azilect in PD patients

Teva Pharmaceutical Industries Ltd. and H. Lundbeck A/S (Lundbeck) today announced newly published long-term data on Azilect(rasagiline tablets) from the TEMPO study and its open-label extension. The findings confirm the long-term efficacy, safety and tolerability of Azilect® in patients with Parkinson's disease (PD) and further demonstrate the benefits obtained with early treatment initiation. The data was published in the June 2010 issue of the International Journal of Neuroscience.

6 Aug 2010

Eliminating depression, diabetes can reduce levels of dementia: Study

Eliminating diabetes and depression, as well as increasing education and fruit and vegetable consumption, are likely to have the biggest impact on reducing levels of dementia in the coming years, should no effective treatment be found, concludes a study published on bmj.com today.These findings suggest priorities for future public health interventions.While the exact cause of dementia is still unknown, several modifiable risk factors have already been identified. These include vascular risk factors (heart disease, stroke, high blood pressure, obesity, diabetes, and high cholesterol), a history of depression, diet, alcohol consumption, and education level.

6 Aug 2010

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Repligen Corporation today reported results for the first quarter of fiscal year 2011, ended June 30, 2010. Total revenue for the first quarter was $7,010,000 compared to total revenue of $5,061,000 for the first quarter of fiscal year 2010, an increase of $1,949,000 or 39%. Bioprocessing product revenue for the first quarter was $4,269,000 compared to $2,473,000 for the first quarter of fiscal 2010, an increase of $1,796,000 or 73%.

5 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

University of Pennsylvania announces recipients of 2010 Templeton Positive Neuroscience Awards

The Positive Psychology Center of the University of Pennsylvania and the John Templeton Foundation have announced the recipients of the 2010 Templeton Positive Neuroscience Awards, $2.9 million given to 15 new research projects at the intersection of neuroscience and positive psychology.

5 Aug 2010

Mothers of premature babies have high levels of stress and anxiety

The incidence of premature babies has been stable or even increased over time. The phenomenon brings with it the possibility of neurological, sensorial, respiratory, cognitive or psychomotor consequences for the child, both in the short and the medium term. These consequences also are a concern to child psychiatrists and psychologists, as it is currently known that the progress of a premature baby and the appearance or otherwise of problems depend largely on the family environment, above all how the mother interacts with her child in the first months of its life.

5 Aug 2010

Amputation can be prevented when patients are treated by podiatric physicians: Study

Amputation, one of the most devastating and costly consequences of diabetes, can be prevented when patients are treated by podiatric physicians. That's the finding of a national, large-scale study co-authored by Dr. James Wrobel, DPM, MS, Associate Professor of Medicine at Rosalind Franklin University of Medicine and Science.

5 Aug 2010

EEG patterns can predict schizophrenia patients' response to clozapine therapy

A commonplace electroencephalography (EEG) test may hold the key to predicting whether a person will respond to certain prescribed drugs, particularly those related to psychiatric conditions.In a study to be published by Clinical Neurophysiology, and now posted online, engineering and health sciences researchers at McMaster University applied machine learning to EEG patterns and successfully predicted how patients with schizophrenia would respond to clozapine therapy.

5 Aug 2010

Research examines effects of orthostatic hypotension in adults, children

A simple variation to the tried and true method of checking blood pressure can reveal startling information about both older and younger persons, new research suggests.

4 Aug 2010

Advocacy intervention does not improve depressive symptoms among abused Chinese women: Study

Among Chinese women who are survivors of intimate partner violence, an advocacy intervention that included empowerment sessions and telephone support from social workers did not result in a clinically meaningful improvement in depressive symptoms, according to a study in the August 4 issue of JAMA, a theme issue on violence and human rights.

4 Aug 2010

Report examines effects of traumatic events on mental health status of adults in Central African Republic

More than three-quarters of adults in the Central African Republic report witnessing or personally experiencing traumatic events during the most recent wave of violence, and more than half meet criteria for depression or anxiety, according to a report in the August 4 issue of JAMA, a theme issue on violence and human rights.

4 Aug 2010

Contrave added to diet and exercise regimen can induce significant weight loss

Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.

4 Aug 2010

Achievement of tenth milestone triggers EUR 2.5 million payment from Boehringer Ingelheim to Evotec

Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.

4 Aug 2010

Warnings on stop smoking drug Champix

The smoking cessation drug Champix (sold in the US as Chantix) has allegedly made fifteen people commit suicide since January 2008 in Australia. Another 191 patients have reported suicidal thoughts and related effects. The latest available figures from the Therapeutic Goods Administration (TGA) suggest a doubling in the numbers of suicides linked to Champix (Varenicline) since July last year with six people committing suicide.

3 Aug 2010

Group skill building intervention programs for foster care children may help improve mental health

Incorporating mentoring and group skill-building intervention programs for children in foster care may help improve mental health outcomes in this population, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

3 Aug 2010

Study shows prevalence, severity of dyspnea in long-term lung cancer survivors

With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.

3 Aug 2010

Depression News and Research

Latest Depression News and Research

Blue Cross of Massachusetts agrees to reduce dramatic rate increases

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

CDS introduces new course on brain injury into its curriculum

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

TEMPO study recommends early administration of Azilect in PD patients

Eliminating depression, diabetes can reduce levels of dementia: Study

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

University of Pennsylvania announces recipients of 2010 Templeton Positive Neuroscience Awards

Mothers of premature babies have high levels of stress and anxiety

Amputation can be prevented when patients are treated by podiatric physicians: Study

EEG patterns can predict schizophrenia patients' response to clozapine therapy

Research examines effects of orthostatic hypotension in adults, children

Advocacy intervention does not improve depressive symptoms among abused Chinese women: Study

Report examines effects of traumatic events on mental health status of adults in Central African Republic

Contrave added to diet and exercise regimen can induce significant weight loss

Achievement of tenth milestone triggers EUR 2.5 million payment from Boehringer Ingelheim to Evotec

Warnings on stop smoking drug Champix

Group skill building intervention programs for foster care children may help improve mental health

Study shows prevalence, severity of dyspnea in long-term lung cancer survivors

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in